君实生物：2025年营收增长28.23%至24.98亿元，商业化药品销售收入与上年同期相比有所增长

财经网03-16

近日，君实生物发布公告称，2025年君实生物实现营业收入24.98亿元，同比增长28.23%；归属于母公司所有者的净利润亏损8.75亿元，上年同期净利润亏损12.81亿元。公司2025年度不进行利润分配，也不进行资本公积转增股本。营业收入同比增长，主要系商业化药品的销售收入与上年同期相比有所增长。归属于上市公司股东的净利润较上年同期亏损减少主要系商业化药品的销售收入与上年同期相比有所增长。 ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2619431806?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-16 13:07","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2619431806","market":"sh","top_or_hot":-1,"title":"君实生物：2025年营收增长28.23%至24.98亿元，商业化药品销售收入与上年同期相比有所增长","media":"财经网","content":"<div>\n<p>近日，君实生物发布公告称，2025年君实生物实现营业收入24.98亿元，同比增长28.23%；归属于母公司所有者的净利润亏损8.75亿元，上年同期净利润亏损12.81亿元。公司2025年度不进行利润分配，也不进行资本公积转增股本。营业收入同比增长，主要系商业化药品的销售收入与上年同期相比有所增长。归属于上市公司股东的净利润较上年同期亏损减少主要系商业化药品的销售收入与上年同期相比有所增长。\n\n\n...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/hk/2026-03-16/doc-inhreeew9895503.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>君实生物：2025年营收增长28.23%至24.98亿元，商业化药品销售收入与上年同期相比有所增长</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n君实生物：2025年营收增长28.23%至24.98亿元，商业化药品销售收入与上年同期相比有所增长\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-16 13:07 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/relnews/hk/2026-03-16/doc-inhreeew9895503.shtml><strong>财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，君实生物发布公告称，2025年君实生物实现营业收入24.98亿元，同比增长28.23%；归属于母公司所有者的净利润亏损8.75亿元，上年同期净利润亏损12.81亿元。公司2025年度不进行利润分配，也不进行资本公积转增股本。营业收入同比增长，主要系商业化药品的销售收入与上年同期相比有所增长。归属于上市公司股东的净利润较上年同期亏损减少主要系商业化药品的销售收入与上年同期相比有所增长。\n\n\n...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/relnews/hk/2026-03-16/doc-inhreeew9895503.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688180","symbol_name":"君实生物","start_time":0,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-16/doc-inhreeew9895503.shtml","article_id":"2619431806","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-16/doc-inhreeew9895503.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2619431806","pubTimestamp":1773637620,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"近日，君实生物发布公告称，2025年君实生物实现营业收入24.98亿元，同比增长28.23%；归属于母公司所有者的净利润亏损8.75亿元，上年同期净利润亏损12.81亿元。公司2025年度不进行利润分配，也不进行资本公积转增股本。营业收入同比增长，主要系商业化药品的销售收入与上年同期相比有所增长。归属于上市公司股东的净利润较上年同期亏损减少主要系商业化药品的销售收入与上年同期相比有所增长。\n\n\n海量资讯、精准解读，尽在新浪财经APP","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"688180":"君实生物","01877":"君实生物"},"translate_title":"Junshi Biotech: Revenue will increase by 28.23% to 2.498 billion yuan in 2025, and commercial drug sales revenue will increase compared with the same period last year","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688180":1.5,"01877":1.5},"content_text":"近日，君实生物发布公告称，2025年君实生物实现营业收入24.98亿元，同比增长28.23%；归属于母公司所有者的净利润亏损8.75亿元，上年同期净利润亏损12.81亿元。公司2025年度不进行利润分配，也不进行资本公积转增股本。营业收入同比增长，主要系商业化药品的销售收入与上年同期相比有所增长。归属于上市公司股东的净利润较上年同期亏损减少主要系商业化药品的销售收入与上年同期相比有所增长。\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2619431806","isCrawlerRequest":true}